Jason Wild first joined the board as Chairman of TerrAscend after leading a private placement into the company in 2017. Having built a deep knowledge base and network in the cannabis industry over the years, Mr. Wild brings strategic value as an investor and partner. He works collaboratively with the board and management team to help guide the company’s strategy and source M&A opportunities with his extensive network.

In addition to his role with TerrAscend, Mr. Wild is the President Chief Investment Officer of JW Asset Management, an SEC registered investment adviser with more than $500 million in assets under management. Starting his first fund in 1998 with under $100,000 in assets, Mr. Wild achieved early success by leveraging his background as a pharmacist finding undervalued, specialty pharmaceutical companies, and focusing on long term price appreciation. He also serves on the board of Vitruvias Therapeutics, a US based generic drug company